Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Eric Poeschla to Immunodeficiency Virus, Feline

This is a "connection" page, showing publications Eric Poeschla has written about Immunodeficiency Virus, Feline.

 
Connection Strength
 
 
 
7.374
 
  1. Morrison JH, Poeschla EM. The Feline Immunodeficiency Virus Envelope Signal Peptide Is a Tetherin Antagonizing Protein. mBio. 2023 04 25; 14(2):e0016123.
    View in: PubMed
    Score: 0.804
  2. Morrison JH, Guevara RB, Marcano AC, Saenz DT, Fadel HJ, Rogstad DK, Poeschla EM. Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation. J Virol. 2014 Mar; 88(6):3255-72.
    View in: PubMed
    Score: 0.425
  3. Kemler I, Saenz D, Poeschla E. Feline immunodeficiency virus Gag is a nuclear shuttling protein. J Virol. 2012 Aug; 86(16):8402-11.
    View in: PubMed
    Score: 0.380
  4. Fadel HJ, Saenz DT, Poeschla EM. Construction and testing of orfA +/- FIV reporter viruses. Viruses. 2012 01; 4(1):184-99.
    View in: PubMed
    Score: 0.371
  5. Saenz DT, Barraza R, Loewen N, Teo W, Poeschla EM. Production, harvest, and concentration of feline immunodeficiency virus-based lentiviral vector from cells grown in CF10 or CF2 devices. Cold Spring Harb Protoc. 2012 Jan 01; 2012(1):118-23.
    View in: PubMed
    Score: 0.370
  6. Saenz DT, Barraza R, Loewen N, Teo W, Poeschla EM. Production and harvest of feline immunodeficiency virus-based lentiviral vector from cells grown in T75 tissue-culture flasks. Cold Spring Harb Protoc. 2012 Jan 01; 2012(1):124-5.
    View in: PubMed
    Score: 0.370
  7. Saenz DT, Barraza R, Loewen N, Teo W, Poeschla EM. Titration of feline immunodeficiency virus-based lentiviral vector preparations. Cold Spring Harb Protoc. 2012 Jan 01; 2012(1):126-8.
    View in: PubMed
    Score: 0.370
  8. Saenz DT, Barraza R, Loewen N, Teo W, Poeschla EM. Feline immunodeficiency virus-based lentiviral vectors. Cold Spring Harb Protoc. 2012 Jan 01; 2012(1):71-6.
    View in: PubMed
    Score: 0.370
  9. Wongsrikeao P, Saenz D, Rinkoski T, Otoi T, Poeschla E. Antiviral restriction factor transgenesis in the domestic cat. Nat Methods. 2011 Sep 11; 8(10):853-9.
    View in: PubMed
    Score: 0.362
  10. Kemler I, Meehan A, Poeschla EM. Live-cell coimaging of the genomic RNAs and Gag proteins of two lentiviruses. J Virol. 2010 Jul; 84(13):6352-66.
    View in: PubMed
    Score: 0.328
  11. Barraza RA, Rasmussen CA, Loewen N, Cameron JD, Gabelt BT, Teo WL, Kaufman PL, Poeschla EM. Prolonged transgene expression with lentiviral vectors in the aqueous humor outflow pathway of nonhuman primates. Hum Gene Ther. 2009 Mar; 20(3):191-200.
    View in: PubMed
    Score: 0.304
  12. Barraza RA, Poeschla EM. Human gene therapy vectors derived from feline lentiviruses. Vet Immunol Immunopathol. 2008 May 15; 123(1-2):23-31.
    View in: PubMed
    Score: 0.281
  13. Khare PD, Loewen N, Teo W, Barraza RA, Saenz DT, Johnson DH, Poeschla EM. Durable, safe, multi-gene lentiviral vector expression in feline trabecular meshwork. Mol Ther. 2008 Jan; 16(1):97-106.
    View in: PubMed
    Score: 0.275
  14. Saenz DT, Teo W, Olsen JC, Poeschla EM. Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins. J Virol. 2005 Dec; 79(24):15175-88.
    View in: PubMed
    Score: 0.243
  15. Kemler I, Azmi I, Poeschla EM. The critical role of proximal gag sequences in feline immunodeficiency virus genome encapsidation. Virology. 2004 Sep 15; 327(1):111-20.
    View in: PubMed
    Score: 0.223
  16. Saenz DT, Poeschla EM. FIV: from lentivirus to lentivector. J Gene Med. 2004 Feb; 6 Suppl 1:S95-104.
    View in: PubMed
    Score: 0.214
  17. Loewen N, Leske DA, Chen Y, Teo WL, Saenz DT, Peretz M, Holmes JM, Poeschla EM. Comparison of wild-type and class I integrase mutant-FIV vectors in retina demonstrates sustained expression of integrated transgenes in retinal pigment epithelium. J Gene Med. 2003 Dec; 5(12):1009-17.
    View in: PubMed
    Score: 0.211
  18. Loewen N, Barraza R, Whitwam T, Saenz DT, Kemler I, Poeschla EM. FIV Vectors. Methods Mol Biol. 2003; 229:251-71.
    View in: PubMed
    Score: 0.198
  19. Kemler I, Barraza R, Poeschla EM. Mapping the encapsidation determinants of feline immunodeficiency virus. J Virol. 2002 Dec; 76(23):11889-903.
    View in: PubMed
    Score: 0.197
  20. Loewen N, Bahler C, Teo WL, Whitwam T, Peretz M, Xu R, Fautsch MP, Johnson DH, Poeschla EM. Preservation of aqueous outflow facility after second-generation FIV vector-mediated expression of marker genes in anterior segments of human eyes. Invest Ophthalmol Vis Sci. 2002 Dec; 43(12):3686-90.
    View in: PubMed
    Score: 0.197
  21. Whitwam T, Peretz M, Poeschla E. Identification of a central DNA flap in feline immunodeficiency virus. J Virol. 2001 Oct; 75(19):9407-14.
    View in: PubMed
    Score: 0.182
  22. Poeschla EM, Looney DJ. CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells. J Virol. 1998 Aug; 72(8):6858-66.
    View in: PubMed
    Score: 0.146
  23. Poeschla EM, Wong-Staal F, Looney DJ. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med. 1998 Mar; 4(3):354-7.
    View in: PubMed
    Score: 0.142
  24. Elinav H, Wu Y, Coskun A, Hryckiewicz K, Kemler I, Hu Y, Rogers H, Hao B, Ben Mamoun C, Poeschla E, Sutton R. Human CRM1 augments production of infectious human and feline immunodeficiency viruses from murine cells. J Virol. 2012 Nov; 86(22):12053-68.
    View in: PubMed
    Score: 0.097
  25. Poeschla EM. Primate and feline lentiviruses in current intrinsic immunity research: the cat is back. Vet Immunol Immunopathol. 2011 Oct 15; 143(3-4):215-20.
    View in: PubMed
    Score: 0.089
  26. Llano M, Vanegas M, Fregoso O, Saenz D, Chung S, Peretz M, Poeschla EM. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J Virol. 2004 Sep; 78(17):9524-37.
    View in: PubMed
    Score: 0.056
  27. Loewen N, Leske DA, Cameron JD, Chen Y, Whitwam T, Simari RD, Teo WL, Fautsch MP, Poeschla EM, Holmes JM. Long-term retinal transgene expression with FIV versus adenoviral vectors. Mol Vis. 2004 Apr 13; 10:272-80.
    View in: PubMed
    Score: 0.054
  28. Saenz DT, Loewen N, Peretz M, Whitwam T, Barraza R, Howell KG, Holmes JM, Good M, Poeschla EM. Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: analysis with class I integrase mutants. J Virol. 2004 Mar; 78(6):2906-20.
    View in: PubMed
    Score: 0.054
  29. Loewen N, Fautsch MP, Peretz M, Bahler CK, Cameron JD, Johnson DH, Poeschla EM. Genetic modification of human trabecular meshwork with lentiviral vectors. Hum Gene Ther. 2001 Nov 20; 12(17):2109-19.
    View in: PubMed
    Score: 0.046
  30. Diaz-Griffero F, Kar A, Lee M, Stremlau M, Poeschla E, Sodroski J. Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp. Virology. 2007 Dec 20; 369(2):400-10.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)